Insider Shareholders with Direct Ownership of Opiant Pharmaceuticals, Inc. (OPNT)
This section provides a comprehensive overview of the insiders with direct ownership of Opiant Pharmaceuticals, Inc. (OPNT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
OPIANT PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Roger Crystal
Chief Executive Officer |
72,850 | 99,975 | 0 $0 | 12 |
Mar 02, 2023
Reduced 100.0%
|
| 24,086 | 37,586 | 0 $0 | 10 |
Mar 02, 2023
Reduced 100.0%
|
|
|
David D O'Toole
Chief Financial Officer |
24,650 | 40,015 | 0 $0 | 12 |
Mar 02, 2023
Reduced 100.0%
|
|
Phil Skolnick
Chief Scientific Officer |
24,198 | 28,348 | 0 $0 | 11 |
Mar 02, 2023
Reduced 100.0%
|
|
Matthew R. Ruth
Chief Commercial Officer |
33,000 | 33,000 | 0 $0 | 7 |
Mar 02, 2023
Reduced 100.0%
|
|
Richard J Daly
Director |
4,000 | 7,800 | 0 $0 | 3 |
Mar 02, 2023
Reduced 100.0%
|
|
Craig A Collard
Director |
53,822 | 55,822 | 0 $0 | 9 |
Mar 02, 2023
Reduced 100.0%
|
|
Mark Jason Heath Ellison
Chief Development Officer |
23,636 | 23,636 | 0 $0 | 8 |
Mar 02, 2023
Reduced 100.0%
|
|
Ann L. Mac Dougall
Director |
30,334 | 42,334 | 0 $0 | 12 |
Mar 02, 2023
Reduced 100.0%
|
|
Gabrielle Alison Silver
Director |
29,834 | 36,349 | 0 $0 | 12 |
Mar 02, 2023
Reduced 100.0%
|
|
Masuoka K. Lorianne
Director |
4,000 | 4,000 | 0 $0 | 3 |
Mar 02, 2023
Reduced 100.0%
|
|
Thomas T. Thomas
Director |
12,334 | 17,334 | 0 $0 | 12 |
Mar 02, 2023
Reduced 100.0%
|
|
Michael Sinclair
Director |
150,000 | 262,720 | 0 $0 | 15 |
Mar 02, 2023
Reduced 100.0%
|